HomeABOS • NASDAQ
add
Acumen Pharmaceuticals Inc
Previous close
$1.05
Day range
$1.00 - $1.08
Year range
$0.90 - $3.92
Market cap
60.88M USD
Avg Volume
222.18K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | -51.59M | -129.64% |
Net income | -37.15M | -125.22% |
Net profit margin | — | — |
Earnings per share | -0.62 | -113.79% |
EBITDA | -39.58M | -114.34% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 171.56M | -29.55% |
Total assets | 238.99M | -22.94% |
Total liabilities | 57.18M | 32.50% |
Total equity | 181.82M | — |
Shares outstanding | 60.57M | — |
Price to book | 0.35 | — |
Return on assets | -39.13% | — |
Return on capital | -43.16% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -37.15M | -125.22% |
Cash from operations | -27.22M | -227.34% |
Cash from investing | 29.66M | 160.78% |
Cash from financing | -9.00K | -100.03% |
Net change in cash | 2.44M | 108.71% |
Free cash flow | -14.78M | -253.77% |
About
Founded
Jan 1, 1996
Headquarters
Website
Employees
61
